Exelon Corporation to Join the NASDAQ-100 Index Beginning November 21, 2019
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Exelon Corporation (Nasdaq: EXC), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the NASDAQ-100 Ex-Tech Sector Index (Nasdaq: NDXX) prior to market open on Thursday, November 21, 2019. Exelon Corporation will replace Celgene Corporation (Nasdaq: CELG) in the indexes.
Exelon Corporation is headquartered in Chicago, Illinois and has a market capitalization of approximately $44 billion. For more information about the company, go to http://www.exeloncorp.com/.About NasdaqNasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.Media Contact: Matthew Sheahan, Nasdaq (212) 231-5945 Matthew.Sheahan@nasdaq.com
Issuer & Investor Contact: Carla Proto, Nasdaq (203) 926-3326